There were 1,798 press releases posted in the last 24 hours and 442,348 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
LAVA Therapeutics Announces Selection by Janssen of Lead Gamma-Delta T-Cell Engager Bispecific Antibody to Move Toward Clinical Development

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image